Cancer Screening Kits

Diagnostic kits for detection and quantification of tumor-associated markers for oncology applications. Supports cancer screening, diagnosis, and treatment monitoring in clinical practice.

Laboratory diagnostic kits for prostate-specific antigen detection and prostate cancer screening. These kits are used in clinical laboratories to support early detection and patient management.

Specialized diagnostic kits for early cancer screening and detection. Targets major cancer types affecting Asian and Chinese populations with focus on preventive medicine applications.

In vitro diagnostic kits for detection and quantification of cancer biomarkers in patient samples. Available in multiple formats including ELISA and CLIA for oncology applications.

Advanced molecular diagnostic kits delivering precision and speed for early disease detection. These kits enable accurate identification of pathogens and genetic markers in clinical specimens.

Rapid screening diagnostic assays that detect key oncology markers including AFP, CEA, PSA, and FOB with low sample volume requirements. Designed to facilitate accessible early-stage risk stratification and are ideal for large-scale population health screening programs.

Specialized in vitro diagnostic test kits for molecular analysis of genetic markers and disease-related sequences. These kits provide rapid and reliable results for clinical molecular pathology applications.

Molecular diagnostic kits for genetic testing applications across hereditary conditions and disease susceptibility screening. Supports preventive medicine and personalized health assessment protocols.

In vitro diagnostic test kits based on microarray chemiluminescence immunoassay technology. These kits employ hard substrate glass slides with covalently bound monoclonal antibodies, enabling parallel testing of multiple biomarkers with enhanced sensitivity and accuracy.

Immunoassay kits for measurement of various tumor markers in serum samples. Supports cancer screening, diagnosis, and surveillance.

PCR-based kits designed to detect specific gene mutations and polymorphisms associated with malignancy. These products enable targeted molecular analysis for precision tumor diagnosis.

Comprehensive test kits for molecular diagnostics utilizing PCR-based detection methods. The kits are designed for reliable identification and quantification of nucleic acid targets in clinical samples. Available in various configurations to meet specific diagnostic requirements.